An analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide

We have previously identified the novel Cancer/Testis antigen PASD1 by immunoscreening a testis library with pooled acute myeloid leukemia (AML) patient sera. To develop a cytotoxic T lymphocyte (CTL)-inducing vaccine, we have now investigated the carboxy-terminal region, known to contain serologica...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Hardwick, Nicola, Buchan, Sarah, Ingram, Wendy, Khan, Ghazala, Vittes, Gisella, Rice, Jason, Pulford, Karen, Mufti, Ghulam, Stevenson, Freda, Guinn, Barbara-ann
Format: Artigo
Jezik:Inglês
Izdano: Academy of Cancer Immunology 2013
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3718735/
https://ncbi.nlm.nih.gov/pubmed/23882161
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items